These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28206698)

  • 1. Fkbp10 Deletion in Osteoblasts Leads to Qualitative Defects in Bone.
    Lietman CD; Lim J; Grafe I; Chen Y; Ding H; Bi X; Ambrose CG; Fratzl-Zelman N; Roschger P; Klaushofer K; Wagermaier W; Schmidt I; Fratzl P; Rai J; Weis M; Eyre D; Keene DR; Krakow D; Lee BH
    J Bone Miner Res; 2017 Jun; 32(6):1354-1367. PubMed ID: 28206698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connective tissue alterations in Fkbp10-/- mice.
    Lietman CD; Rajagopal A; Homan EP; Munivez E; Jiang MM; Bertin TK; Chen Y; Hicks J; Weis M; Eyre D; Lee B; Krakow D
    Hum Mol Genet; 2014 Sep; 23(18):4822-31. PubMed ID: 24777781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized chondro-ossification underlies joint dysfunction and motor deficits in the
    Lim J; Lietman C; Grol MW; Castellon A; Dawson B; Adeyeye M; Rai J; Weis M; Keene DR; Schweitzer R; Park D; Eyre DR; Krakow D; Lee BH
    Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34161280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Type I Collagen Telopeptide Lysyl Hydroxylation Causes Musculoskeletal Abnormalities in a Zebrafish Model of Bruck Syndrome.
    Gistelinck C; Witten PE; Huysseune A; Symoens S; Malfait F; Larionova D; Simoens P; Dierick M; Van Hoorebeke L; De Paepe A; Kwon RY; Weis M; Eyre DR; Willaert A; Coucke PJ
    J Bone Miner Res; 2016 Nov; 31(11):1930-1942. PubMed ID: 27541483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kuskokwim syndrome, a recessive congenital contracture disorder, extends the phenotype of FKBP10 mutations.
    Barnes AM; Duncan G; Weis M; Paton W; Cabral WA; Mertz EL; Makareeva E; Gambello MJ; Lacbawan FL; Leikin S; Fertala A; Eyre DR; Bale SJ; Marini JC
    Hum Mutat; 2013 Sep; 34(9):1279-88. PubMed ID: 23712425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of FKBP10 in recessive type XI osteogenesis imperfecta leads to diminished collagen cross-linking and reduced collagen deposition in extracellular matrix.
    Barnes AM; Cabral WA; Weis M; Makareeva E; Mertz EL; Leikin S; Eyre D; Trujillo C; Marini JC
    Hum Mutat; 2012 Nov; 33(11):1589-98. PubMed ID: 22718341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome.
    Kelley BP; Malfait F; Bonafe L; Baldridge D; Homan E; Symoens S; Willaert A; Elcioglu N; Van Maldergem L; Verellen-Dumoulin C; Gillerot Y; Napierala D; Krakow D; Beighton P; Superti-Furga A; De Paepe A; Lee B
    J Bone Miner Res; 2011 Mar; 26(3):666-72. PubMed ID: 20839288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations Between Bone Mechanical Properties and Bone Composition Parameters in Mouse Models of Dominant and Recessive Osteogenesis Imperfecta and the Response to Anti-TGF-β Treatment.
    Bi X; Grafe I; Ding H; Flores R; Munivez E; Jiang MM; Dawson B; Lee B; Ambrose CG
    J Bone Miner Res; 2017 Feb; 32(2):347-359. PubMed ID: 27649409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Wnt signaling improves bone mass and strength, but not brittleness, in the Col1a1(+/mov13) mouse model of type I Osteogenesis Imperfecta.
    Jacobsen CM; Schwartz MA; Roberts HJ; Lim KE; Spevak L; Boskey AL; Zurakowski D; Robling AG; Warman ML
    Bone; 2016 Sep; 90():127-32. PubMed ID: 27297606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and molecular characterization of Chinese patients with FKBP10 variants.
    Tan Z; Shek HT; Chen P; Dong Z; Zhou Y; Yin S; Qiu A; Dong L; Gao B; To MKT
    Mol Genet Genomic Med; 2023 Apr; 11(4):e2122. PubMed ID: 36655627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First mouse model for combined osteogenesis imperfecta and Ehlers-Danlos syndrome.
    Chen F; Guo R; Itoh S; Moreno L; Rosenthal E; Zappitelli T; Zirngibl RA; Flenniken A; Cole W; Grynpas M; Osborne LR; Vogel W; Adamson L; Rossant J; Aubin JE
    J Bone Miner Res; 2014 Jun; 29(6):1412-23. PubMed ID: 24443344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoblastic differentiation of bone marrow mesenchymal stromal cells in Bruck Syndrome.
    Kaneto CM; Lima PS; Zanette DL; Oliveira TY; de Assis Pereira F; Lorenzi JC; Dos Santos JL; Prata KL; Neto JM; de Paula FJ; Silva WA
    BMC Med Genet; 2016 May; 17(1):38. PubMed ID: 27146342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic Spectrum in Osteogenesis Imperfecta Due to Mutations in TMEM38B: Unraveling a Complex Cellular Defect.
    Webb EA; Balasubramanian M; Fratzl-Zelman N; Cabral WA; Titheradge H; Alsaedi A; Saraff V; Vogt J; Cole T; Stewart S; Crabtree NJ; Sargent BM; Gamsjaeger S; Paschalis EP; Roschger P; Klaushofer K; Shaw NJ; Marini JC; Högler W
    J Clin Endocrinol Metab; 2017 Jun; 102(6):2019-2028. PubMed ID: 28323974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique micro- and nano-scale mineralization pattern of human osteogenesis imperfecta type VI bone.
    Fratzl-Zelman N; Schmidt I; Roschger P; Roschger A; Glorieux FH; Klaushofer K; Wagermaier W; Rauch F; Fratzl P
    Bone; 2015 Apr; 73():233-41. PubMed ID: 25554599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel splicing mutation in FKBP10 causing osteogenesis imperfecta with a possible mineralization defect.
    Venturi G; Monti E; Dalle Carbonare L; Corradi M; Gandini A; Valenti MT; Boner A; Antoniazzi F
    Bone; 2012 Jan; 50(1):343-9. PubMed ID: 22061863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing defect in FKBP10 gene causes autosomal recessive osteogenesis imperfecta disease: a case report.
    Maghami F; Tabei SMB; Moravej H; Dastsooz H; Modarresi F; Silawi M; Faghihi MA
    BMC Med Genet; 2018 May; 19(1):86. PubMed ID: 29801479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Follow-Up Outcomes of 19 Patients with Osteogenesis Imperfecta Type XI and Bruck Syndrome Type I Caused by FKBP10 Variants.
    Yüksel Ülker A; Uludağ Alkaya D; Elkanova L; Şeker A; Akpınar E; Akarsu NA; Uyguner ZO; Tüysüz B
    Calcif Tissue Int; 2021 Dec; 109(6):633-644. PubMed ID: 34173012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen.
    Schwarze U; Cundy T; Pyott SM; Christiansen HE; Hegde MR; Bank RA; Pals G; Ankala A; Conneely K; Seaver L; Yandow SM; Raney E; Babovic-Vuksanovic D; Stoler J; Ben-Neriah Z; Segel R; Lieberman S; Siderius L; Al-Aqeel A; Hannibal M; Hudgins L; McPherson E; Clemens M; Sussman MD; Steiner RD; Mahan J; Smith R; Anyane-Yeboa K; Wynn J; Chong K; Uster T; Aftimos S; Sutton VR; Davis EC; Kim LS; Weis MA; Eyre D; Byers PH
    Hum Mol Genet; 2013 Jan; 22(1):1-17. PubMed ID: 22949511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFT20 is critical for collagen biosynthesis in craniofacial bone formation.
    Yamaguchi H; Terajima M; Kitami M; Wang J; He L; Saeki M; Yamauchi M; Komatsu Y
    Biochem Biophys Res Commun; 2020 Dec; 533(4):739-744. PubMed ID: 32988591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII.
    Fratzl-Zelman N; Morello R; Lee B; Rauch F; Glorieux FH; Misof BM; Klaushofer K; Roschger P
    Bone; 2010 Mar; 46(3):820-6. PubMed ID: 19895918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.